Use of angiogenin or angiogenin agonists for treating diseases and disorders
US9789168B2 · kind B2 · utility
1Cited by
8References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 28, 2015 |
| Grant date | Oct 17, 2017 |
| Priority date | — |
| Expiry date | Jul 28, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y301/27
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a method of treating a disorder characterized by elevated or dysregulated myostatin, disorders where the interaction between follistatin and angiogenin can be used to improve function in tissues, neurological diseases or disorders, spinal injuries or diseases, bone diseases or disorders, diseases involving glucose homeostasis, wound healing, neuroprotection, nervous system functional support or managing metabolic diseases, the method comprising administering an effective amount of angiogenin or an angiogenin agonist. Compositions and neutraceuticals comprising angiogenin are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.